Medicine

E. Tacconelli, E. Carrara, A. Savoldi, S. Harbarth, M. Mendelson, D. Monnet, C. Pulcini, G. Kahlmeter, J. Kluytmans, Y. Carmeli, M. Ouellette, Kevin Outterson, J. Patel, M. Cavaleri, E. Cox, Chris R Houchens, M. Grayson, P. Hansen, Nalini Singh, U. Theuretzbacher, N. Magrini, A. Aboderin, S. Al-Abri, Nordiah Awang Jalil, N. Benzonana, S. Bhattacharya, A. Brink, F. Burkert, O. Cars, G. Cornaglia, O. Dyar, A. Friedrich, A. Gales, Sumanth Gandra, C. Giske, D. Goff, H. Goossens, T. Gottlieb, M. Guzman Blanco, W. Hryniewicz, D. Kattula, Tim Jinks, S. Kanj, Lawrence Kerr, M. Kieny, Yang Soo Kim, R. Kozlov, J. Labarca, R. Laxminarayan, K. Leder, L. Leibovici, Gabriel Levy-Hara, Jasper Littman, S. Malhotra-Kumar, V. Manchanda, L. Moja, B. Ndoye, Angelo Pan, D. Paterson, M. Paul, Haibo Qiu, P. Ramón-Pardo, J. Rodríguez-Baño, M. Sanguinetti, S. Sengupta, M. Sharland, Massinissa Si-Mehand, L. Silver, W. Song, M. Steinbakk, Jens Thomsen, G. Thwaites, Jos W. M. van der Meer, N. van Kinh, S. Vega, M. Villegas, A. Wechsler-Fördös, H. Wertheim, Evelyn Wesangula, N. Woodford, Fidan Yilmaz, Anna Zorzet

2017.12.21LANCET INFECTIOUS DISEASES

DOI: 10.1016/s1473-3099(17)30753-3

tlooto Summary

Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.

Abstract

Abstract is not available.

Citation format

TACCONELLI, E., et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. LANCET INFECTIOUS DISEASES, 2017, 18 3: 318–327.